Cybin (HELP) Current Leases (2023 - 2024)

Cybin (HELP) posted quarterly Current Leases of $97496.1 for Q3 2024, down 37.1% on a QoQ basis from $155001.8 in Q2 2024.

Cybin (HELP) Current Leases (2023 - 2024) Analysis & Trends

Cybin (HELP) has reported Current Leases for 2 consecutive years, with $97496.1 the latest figure, recorded in Q3 2024.

Quarterly Current Leases changed N/A year-over-year to $97496.1 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $97496.1 (changed N/A YoY) and the FY2024 annual result came in at $215954.9, changed N/A from the prior year.
Current Leases declined to $97496.1 in Q3 2024 per HELP's latest filing, from $155001.8 in the prior quarter.
Over the last five years, Current Leases for HELP reached as high as $237989.5 in Q4 2023 and fell as low as $97496.1 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	531,233.95
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	20.58 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	872,589.03
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	720.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	11.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	16.61 Mn
10	Cybin	28.04 Mn	28.04 Mn	-	-

Download Data